Carl Zeiss Meditec AG

AFXA

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,798

Stocks News & Analysis

stocks

Avoid these overvalued ASX shares

The two shares with the highest price to fair value in our Australian coverage.
stocks

Going into earnings, is Microsoft stock a buy, a sell, or fairly valued?

Watching AI monetization, capex’s impact on margins, and guidance on Azure.
stocks

Lithium’s latest drop and what it means for ASX investors

Volatility returns to the lithium market.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,004.9014.700.16%
CAC 408,428.6265.480.78%
DAX 4025,212.08200.730.80%
Dow JONES (US)52,224.64385.380.74%
FTSE 10010,682.8096.890.92%
HKSE24,892.66239.63-0.95%
NASDAQ25,837.21329.131.29%
Nikkei 22566,115.60116.59-0.18%
NZX 50 Index13,763.18107.150.78%
S&P 5007,509.2065.920.89%
S&P/ASX 2008,823.0016.500.19%
SSE Composite Index3,867.032.670.07%

Market Movers